| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
332 |
| Employees |
10,500 |
| Revenues (TTM) (Millions $) |
16,096 |
| Net Income (TTM) (Millions $) |
-2,479 |
| Cash Flow (TTM) (Millions $) |
211 |
| Capital Exp. (TTM) (Millions $) |
479 |
Business Description
Allergan plc is a global pharmaceutical company that was founded in 1950 in California, USA. It specializes in developing, manufacturing, and marketing branded pharmaceuticals, biologics, medical devices, and over-the-counter products for the treatment of neurological, ophthalmologic, medical aesthetics, and gastroenterological conditions.
Allergan is based in Dublin, Ireland, and operates in around 100 countries worldwide. It employs more than 18,000 people across its research and development, manufacturing, and commercial operations. In 2020, the company reported annual revenue of $16.6 billion.
The company's portfolio of products includes Botox, which is used for cosmetic and medical purposes, as well as treatments for eye diseases, migraines, irritable bowel syndrome, and other conditions. Some of Allergan's leading brands include Juvederm, Coolsculpting, Latisse, Restasis, and Ozurdex.
Allergan has a strong focus on research and development, investing heavily in clinical trials and innovation. The company has research facilities in the US, Europe, and Asia, and collaborates with other organizations and academic institutions to advance scientific discovery in its areas of focus.
In 2019, Allergan was acquired by AbbVie, a research-based pharmaceutical company based in North Chicago, Illinois, in a deal worth $63 billion. The acquisition positioned AbbVie as a leading pharmaceutical company with a diverse portfolio of medicines and products, including Allergan's portfolio of medical aesthetics and eye care products.
Overall, Allergan is a leading global pharmaceutical company with a strong reputation for innovation and a diverse portfolio of products that help improve the lives of patients.
Company Address: Clonshaugh Business and Technology Park Dublin 0
Company Phone Number: 261-7000 Stock Exchange / Ticker: NYSE AGN
|
%
33.33% 
60.96 %